Skip to content
CAR-TCR_Boston_2020_Final - Copy

August 31-September 2, 2021

  • Home
  • About
    • About Event
    • Who Attends
    • Venue
    • Meet the Team
  • What’s On
    • Full Event Guide
    • Poster Session
  • News & Media
    • Content Hub
      • Industry Insights
      • Critical Pathfinding
      • Targeting Multiple Myeloma
    • Patient’s Stories
    • Summit Photo Gallery
  • Partnership
    • Partnership Opportunities
    • Partners
    • Industry Partners
    • Media Partners
  • Get Involved
    • Register Interest
    • Contact us

Sexton Biotechnologies

By csamuel | 13th February 2020

Sexton Biotechnologies is a biotechnology company focused on the development of bioproduction tools for cell and gene therapy founded in 2019 as a spin out of Cook Regentec, a life science incubator/accelerator located in Indianapolis, IN. Sexton develops purpose-built CGT tools and media to enable flexible automation and scaling of cell manufacturing processes to increase the probability of positive clinical outcomes and reduce time-to-market, failure points, and labor costs. Sexton’s portfolio includes the CellSeal platform of cryo-storage tools and fill/finish systems and human platelet lysate growth supplements.

https://sextonbio.com/

OUR CONTACT DETAILS

T: +1 617 455 4188
E: info@hansonwade.com

Lost?

Event Guide

Register Interest

ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

SEARCH

ORGANISED BY

HansonWade Logo

Terms & Conditions

Privacy Policy

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok